The presence of nitazenes on the unregulated drug market has risen steeply in the last seven years—prompting UK and international bodies to issue public health warnings about their use. King’s College London research, published in Clinical Toxicology, sheds light on the UK’s growing synthetic opioid problem.
Continue Reading this article here
